{"id":"insulin-eye-drops","safety":{"commonSideEffects":[{"rate":null,"effect":"Ocular irritation"},{"rate":null,"effect":"Conjunctival hyperemia"},{"rate":null,"effect":"Foreign body sensation"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin has been shown to have regenerative and anti-inflammatory properties in ocular tissues. When applied as eye drops, insulin may stimulate epithelial cell growth factors and reduce inflammatory cytokines at the ocular surface, potentially accelerating corneal healing and improving symptoms in dry eye or corneal damage conditions.","oneSentence":"Insulin eye drops deliver insulin topically to the ocular surface to promote corneal epithelial healing and reduce inflammation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:49:08.338Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Corneal epithelial defects and corneal healing"},{"name":"Dry eye disease"}]},"trialDetails":[{"nctId":"NCT02846571","phase":"PHASE1, PHASE2","title":"Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye","status":"RECRUITING","sponsor":"Midhat H. Abdulreda","startDate":"2019-12-05","conditions":"Diabetes","enrollment":2},{"nctId":"NCT05692739","phase":"PHASE4","title":"Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye","status":"COMPLETED","sponsor":"Barbara Burgos Blasco","startDate":"2022-10-19","conditions":"Dry Eye, Insulin","enrollment":116},{"nctId":"NCT07407101","phase":"NA","title":"Impact of Filtration on Autologous Serum Eye Drops","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Limoges","startDate":"2026-04-30","conditions":"Dry Eye Syndrome (DES)","enrollment":10},{"nctId":"NCT05206877","phase":"PHASE1","title":"Topical Insulin for Glaucoma","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-04-01","conditions":"Glaucoma","enrollment":52},{"nctId":"NCT06956846","phase":"PHASE4","title":"Efficacy of Topical Insuline in Corneal Epithelial Healing Post PRK","status":"NOT_YET_RECRUITING","sponsor":"Hotel Dieu de France Hospital","startDate":"2025-04-25","conditions":"Corneal Epithelial Wound Healing","enrollment":100},{"nctId":"NCT06939959","phase":"PHASE4","title":"Evaluating the Efficacy of Topical Insulin for the Restoration of Ocular Surface Interface in Dry Eye Disease.","status":"RECRUITING","sponsor":"Khyber Teaching Hospital","startDate":"2025-04-14","conditions":"Dry Eye, Insulin Sensitivity","enrollment":126},{"nctId":"NCT06931041","phase":"PHASE3","title":"Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye: A Randomized Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto de Oftalmología Fundación Conde de Valenciana","startDate":"2024-02-01","conditions":"Dry Eye, Sjogren Syndrome","enrollment":25},{"nctId":"NCT06601101","phase":"PHASE3","title":"Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus","status":"RECRUITING","sponsor":"University of Campinas, Brazil","startDate":"2024-08-01","conditions":"Keratoconus, Cornea Disease, Eye Diseases","enrollment":36},{"nctId":"NCT06017362","phase":"PHASE4","title":"Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors","status":"RECRUITING","sponsor":"Barbara Burgos Blasco","startDate":"2023-02-08","conditions":"Dry Eye, Glaucoma","enrollment":100},{"nctId":"NCT04118920","phase":"PHASE1","title":"Safety of Topical Insulin Drops for Open-angle Glaucoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-03-27","conditions":"Glaucoma","enrollment":18},{"nctId":"NCT06331910","phase":"PHASE4","title":"Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-04-01","conditions":"Neurotrophic Keratopathy","enrollment":14},{"nctId":"NCT05321251","phase":"PHASE2, PHASE3","title":"Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2022-06-01","conditions":"Neurotrophic Keratitis","enrollment":""},{"nctId":"NCT05940376","phase":"","title":"Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy","status":"UNKNOWN","sponsor":"Benha University","startDate":"2023-07-15","conditions":"Corneal Ulcer, Neurotrophic Corneal Ulcer, Diabetes Mellitus","enrollment":30},{"nctId":"NCT05331859","phase":"PHASE1","title":"Topical Insulin Versus Autologous Serum After Corneal Surgeries","status":"UNKNOWN","sponsor":"Benha University","startDate":"2022-05","conditions":"Corneal Epithelial Wound","enrollment":250},{"nctId":"NCT04877210","phase":"PHASE1","title":"Effects of Topical Insulin on Levels of Tear Inflammatory Mediators","status":"UNKNOWN","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2020-10-22","conditions":"Dry Eye","enrollment":60},{"nctId":"NCT04820010","phase":"","title":"Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3","status":"COMPLETED","sponsor":"Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.","startDate":"2018-10-01","conditions":"Corneal Ulcer, Corneal Perforation, Corneal Epithelium Defect","enrollment":20},{"nctId":"NCT03578991","phase":"NA","title":"Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease","status":"COMPLETED","sponsor":"Parc Sanitari Pere Virgili","startDate":"2019-07-01","conditions":"Patients Aged 65-85 (Both Included), Diagnosed of Mild Cognitive Impairment, Diagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years","enrollment":54},{"nctId":"NCT01031888","phase":"PHASE1","title":"Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2008-03","conditions":"Corneal Epithelial Defects After Ocular Surgeries","enrollment":18},{"nctId":"NCT00865813","phase":"NA","title":"Biopsy Incisional With Trepan in Periocular Lesions","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2008-12","conditions":"Tumor","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":42,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"insulin eye drops","genericName":"insulin eye drops","companyName":"Hotel Dieu de France Hospital","companyId":"hotel-dieu-de-france-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Insulin eye drops deliver insulin topically to the ocular surface to promote corneal epithelial healing and reduce inflammation. Used for Corneal epithelial defects and corneal healing, Dry eye disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}